期刊文献+

血清半胱氨酸蛋白酶抑制剂C与尿微量白蛋白联合检测对原发性高血压肾损害的诊断价值 被引量:2

下载PDF
导出
摘要 目的评价血清半胱氨酸蛋白酶抑制剂C(简称Cystatin C)和尿微量白蛋白(U-mAlb)在诊断高血压肾损害的临床应用。方法对68例高血压患者和35例健康体检者分别进行血肌酐、血清CystatinC和U-mAlb浓度测定,比较其结果。结果U-mAlb在肌酐清除率(Ccr)>80ml/min时与对照组相比已经开始升高(P<0.01),血清CystatinC升高晚于U-mAlb,在Ccr为50~80ml/min时与对照组相比差异有高度显著性(P<0.01)。结论在诊断原发性高血压肾损害时,U-mAlb比CystatinC有更好的敏感度,两项指标联合检测有助于提高诊断准确率。
作者 吴建红 朱蔚
出处 《右江民族医学院学报》 2009年第6期980-981,共2页 Journal of Youjiang Medical University for Nationalities
  • 相关文献

参考文献6

二级参考文献23

  • 1俸家富,罗军,李少林.胱抑素C——肾小球滤过率肌酐替代标记物[J].国外医学(临床生物化学与检验学分册),2005,26(3):168-172. 被引量:111
  • 2叶任高主编.内科学:第5版[M].北京:人民卫生出版社,2002.466.
  • 3Strevens H. Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomcrular endotheliosis in normal, hypertensive and preeclamptic pregnancies. BJOG, 2003, 110(9): 825-830.
  • 4Herget-Rosenthal S, Trabold S, Huesing J, et al. Cystatin C-an accurate marker of glomerular filtration rate after renal transplantat on? Transpl Int, 2000, 13(4): 285-289.
  • 5Janowski R, Kozak M, Jankowska E, et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol, 2001, 8(4): 316-320.
  • 6Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superiot to serum creatinine as a marker of Kidney function., a meta-analysis. Am J Kidney Dis, 2002, 40(2): 221-226.
  • 7Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem, 2001, 47(11): 2055-2059.
  • 8Bokenkamp A, van-Wijk JA, Lentze MJ, et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem, 2002, 48(7):1123-1126.
  • 9Schmitt R, Bachmann S. Impact of thyroid dysfunction on serum cystatin C. Kidney Int, 2003, 64(3): 1139-1140.
  • 10Wiesli P, Schwegler B, Spinas GA, et al. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta, 2003,338(1-2): 87-90.

共引文献257

同被引文献40

  • 1汪国海,霍勇,王梦德,邢厚恂,刘平,臧桐华,徐希平.轻中度高血压人群叶酸与同型半胱氨酸水平的相关分析[J].疾病控制杂志,2007,11(2):171-173. 被引量:14
  • 2Li J, Shi M,Zhang H,et al.Relation of homocysteine to early nephropathy in patients with Type 2 diabetes[J].Clin Nephrol,2012,77(4):305-310.
  • 3Lee SH,Park SA,Ko SH,et al.Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients[J].Metabolism,2010,59(2):241-246.
  • 4Lewerin C,Ljungman S,Nilsson-Ehle H.Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly[J].J Intern Med,2007,261(1):65-73.
  • 5陆再英;钟南山.内科学[M]{H}北京:人民卫生出版社,200891-92.
  • 6Miyoshi H,Mizuguchi Y,Oishi Y. Early detection of abnormal left atrial-left ventricular-arterial coupling in preclinical patients with cardiovascular risk factors:evaluation by two-dim ensionalspeckle-trackingechocardiography[J].{H}Eur J Echocardiography,2011,(06):431-439.
  • 7Praddaude F,Cousins SW,Pecher C. Angiotensin Ⅱ-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium[J].{H}EXPERIMENTAL EYE RESEARCH,2009,(01):109-118.
  • 8Punzi H,Neutel JM,Kereiakes DJ. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension:the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) Study[J].Ther Adv Cardiovasc Dis,2010,(04):209-221.
  • 9李静.老年原发性高血压患者检测MALB对早期肾损害的临床意义[J]医药前沿,2012(21):206.
  • 10Dhingra R,Pencina MJ,Schrader P. Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community[J].{H}CIRCULATION,2009,(08):1101-1107.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部